Prelude Therapeutics Inc (PRLD)
3.86
-0.13
(-3.26%)
USD |
NASDAQ |
May 03, 16:00
3.82
-0.04
(-1.04%)
After-Hours: 20:00
Prelude Therapeutics 1 Year Total Returns (Daily): -39.31% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -39.31% |
May 02, 2024 | -37.66% |
May 01, 2024 | -39.45% |
April 30, 2024 | -41.64% |
April 29, 2024 | -40.56% |
April 26, 2024 | -32.39% |
April 25, 2024 | -31.18% |
April 24, 2024 | -38.67% |
April 23, 2024 | -36.97% |
April 22, 2024 | -37.30% |
April 19, 2024 | -43.12% |
April 18, 2024 | -52.49% |
April 17, 2024 | -48.01% |
April 16, 2024 | -39.53% |
April 15, 2024 | -30.66% |
April 12, 2024 | -26.82% |
April 11, 2024 | -31.50% |
April 10, 2024 | -29.18% |
April 09, 2024 | -18.99% |
April 08, 2024 | -23.70% |
April 05, 2024 | -24.56% |
April 04, 2024 | -21.78% |
April 03, 2024 | -28.48% |
April 02, 2024 | -18.95% |
April 01, 2024 | -17.72% |
Date | Value |
---|---|
March 28, 2024 | -20.34% |
March 27, 2024 | -23.92% |
March 26, 2024 | -28.42% |
March 25, 2024 | -28.42% |
March 22, 2024 | -22.70% |
March 21, 2024 | -19.26% |
March 20, 2024 | -28.08% |
March 19, 2024 | -28.19% |
March 18, 2024 | -31.01% |
March 15, 2024 | -27.30% |
March 14, 2024 | -25.79% |
March 13, 2024 | -21.69% |
March 12, 2024 | -32.01% |
March 11, 2024 | -32.17% |
March 08, 2024 | -26.70% |
March 07, 2024 | -26.51% |
March 06, 2024 | -29.44% |
March 05, 2024 | -32.19% |
March 04, 2024 | -30.56% |
March 01, 2024 | -22.60% |
February 29, 2024 | -24.03% |
February 28, 2024 | -26.33% |
February 27, 2024 | -24.91% |
February 26, 2024 | -26.04% |
February 23, 2024 | -31.37% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.39%
Minimum
May 09 2022
62.38%
Maximum
May 11 2023
-50.26%
Average
-56.94%
Median
Sep 12 2023
1 Year Total Returns (Daily) Benchmarks
CEL-SCI Corp | -27.23% |
AIM ImmunoTech Inc | -15.65% |
IGC Pharma Inc | 53.98% |
NovaBay Pharmaceuticals Inc | -90.79% |
Protalix BioTherapeutics Inc | -63.81% |